Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [18F]FDG Positron Emission Tomography

被引:8
|
作者
Zhang, Hannah J. [1 ]
Mitchell, Samuel [1 ]
Fang, Yong-Hu [2 ]
Tsai, Hsiu-Ming [3 ]
Piao, Lin [2 ]
Ousta, Alaa [2 ]
Leoni, Lara [3 ]
Chen, Chin-Tu [1 ]
Sharp, Willard W. [2 ]
机构
[1] Univ Chicago, Dept Radiol, 5814 S Maryland Ave, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Sect Emergency Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
[3] Univ Chicago, Off Shared Res Facil, 5814 S Maryland Ave, Chicago, IL 60637 USA
关键词
Cardiac arrest; Resuscitation; Brain glucose metabolism; F-18]Fluorodeoxyglucose (FDG); Positron emission tomography (PET); Cerebral injury; COMATOSE PATIENTS; F-18-FDG; DIFFUSION; RESUSCITATION; SURVIVAL; LIVER; PET; SUV;
D O I
10.1007/s12028-020-00984-6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Cardiac arrest (CA) patients who survived by cardiopulmonary resuscitation (CPR) can present different levels of neurological deficits ranging from minor cognitive impairments to persistent vegetative state and brain death. The pathophysiology of the resulting brain injury is poorly understood, and whether changes in post-CA brain metabolism contribute to the injury are unknown. Here we utilized [F-18]fluorodeoxyglucose (FDG)-Positron emission tomography (PET) to study in vivo cerebral glucose metabolism 72 h following CA in a murine CA model. Methods Anesthetized and ventilated adult C57BL/6 mice underwent 12-min KCl-induced CA followed by CPR. Seventy-two hours following CA, surviving mice were intraperitoneally injected with [F-18]FDG ( 186 mu Ci/200 mu L) and imaged on Molecubes preclinical micro-PET/computed tomography (CT) imaging systems after a 30-min awake uptake period. Brain [F-18]FDG uptake was determined by the VivoQuant software on fused PET/CT images with the 3D brain atlas. Upon completion of Positron emission tomography (PET) imaging, remaining [F-18]FDG radioactivity in the brain, heart, and liver was determined using a gamma counter. Results Global increases in brain [F-18]FDG uptake in post-CA mice were observed compared to shams and controls. The median standardized uptake value of [F-18]FDG for CA animals was 1.79 versus sham 1.25 (p < 0.05) and control animals 0.78 (p < 0.01). This increased uptake was consistent throughout the 60-min imaging period and across all brain regions reaching statistical significance in the midbrain, pons, and medulla. Biodistribution analyses of various key organs yielded similar observations that the median [F-18]FDG uptake for brain was 7.04%ID/g tissue for CA mice versus 5.537%ID/g tissue for sham animals, p < 0.05). Conclusions This study has successfully applied [F-18]FDG-PET/CT to measure changes in brain metabolism in a murine model of asystolic CA. Our results demonstrate increased [F-18]FDG uptake in the brain 72 h following CA, suggesting increased metabolic demand in the case of severe neurological injury. Further study is warranted to determine the etiology of these changes.
引用
收藏
页码:64 / 72
页数:9
相关论文
共 50 条
  • [1] Assessment of Brain Glucose Metabolism Following Cardiac Arrest by [18F]FDG Positron Emission Tomography
    Hannah J. Zhang
    Samuel Mitchell
    Yong-Hu Fang
    Hsiu-Ming Tsai
    Lin Piao
    Alaa Ousta
    Lara Leoni
    Chin-Tu Chen
    Willard W. Sharp
    [J]. Neurocritical Care, 2021, 34 : 64 - 72
  • [2] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    Ly, K. H.
    Vidal, E.
    [J]. REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 417 - 427
  • [3] Vasculitis assessment with [18F]FDG positron emission tomography
    Liozon, E.
    Monteil, J.
    [J]. MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2008, 32 (10): : 511 - 522
  • [4] Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18F]FDG Positron Emission Tomography and Autoradiography
    Putzu, Alessandro
    Valtorta, Silvia
    Di Grigoli, Giuseppe
    Haenggi, Matthias
    Belloli, Sara
    Malgaroli, Antonio
    Gemma, Marco
    Landoni, Giovanni
    Beretta, Luigi
    Moresco, Rosa Maria
    [J]. NEUROCRITICAL CARE, 2018, 28 (03) : 370 - 378
  • [5] Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [18F]FDG Positron Emission Tomography and Autoradiography
    Alessandro Putzu
    Silvia Valtorta
    Giuseppe Di Grigoli
    Matthias Haenggi
    Sara Belloli
    Antonio Malgaroli
    Marco Gemma
    Giovanni Landoni
    Luigi Beretta
    Rosa Maria Moresco
    [J]. Neurocritical Care, 2018, 28 : 370 - 378
  • [6] Positron emission tomography with [18F]-FDG in oncology
    Talbot, JN
    Petegnief, Y
    Kerrou, K
    Montravers, F
    Grahek, D
    Younsi, N
    [J]. NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2003, 504 (1-3): : 129 - 138
  • [7] Radionuclide impurities in [18F]F- and [18F]FDG for positron emission tomography
    Koehler, M.
    Degering, D.
    Zessin, J.
    Fuechtner, F.
    Konheiser, J.
    [J]. APPLIED RADIATION AND ISOTOPES, 2013, 81 : 268 - 271
  • [8] Assessment of GABA, receptor mediated changes in regional brain glucose metabolism by the positron emission tomography (PET) radiotracer, 2-deoxy-2-[18f]fluoro-D-glucose ([18f]FDG)
    Waterhouse, RN
    Chang, RC
    Carambot, PE
    Nerantzinis, C
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 242S - 243S
  • [9] Use of [18F] FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection
    Daly, Kevin P.
    Dearling, Jason L. J.
    Seto, Tatsuichiro
    Dunning, Patricia
    Fahey, Frederic
    Packard, Alan B.
    Briscoe, David M.
    [J]. TRANSPLANTATION, 2015, 99 (09) : E132 - E139
  • [10] Hypoxia and glucose metabolism in malignant tumors:: Evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging
    Rajendran, JG
    Mankoff, DA
    O'Sullivan, F
    Peterson, LM
    Schwartz, DL
    Conrad, EU
    Spence, AM
    Muzi, M
    Farwell, DG
    Krohn, KA
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (07) : 2245 - 2252